Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response

Matthew J. Webber, John B. Matson, Vibha K. Tamboli, Samuel I Stupp

Research output: Contribution to journalArticle

134 Citations (Scopus)

Abstract

New biomaterials that have the ability to locally suppress an immune response could have broad therapeutic use in the treatment of diseases characterized by acute or chronic inflammation or as a strategy to facilitate improved efficacy in cell or tissue transplantation. We report here on the preparation of a modular peptide amphiphile (PA) capable of releasing an anti-inflammatory drug, dexamethasone (Dex), by conjugation via a labile hydrazone linkage. This molecule self-assembled in water into long supramolecular nanofibers when mixed with a similar PA lacking the drug conjugate, and the addition of calcium salt to screen electrostatic repulsion between nanofibers promoted gel formation. These nanofiber gels demonstrated sustained release of soluble Dex for over one month in physiologic media. The Dex released from these gels maintained its anti-inflammatory activity when evaluated in vitro using a human inflammatory reporter cell line and furthermore preserved cardiomyocyte viability upon induced oxidative stress. The ability of this gel to mitigate the inflammatory response in cell transplantation strategies was evaluated using cell-surrogate polystyrene microparticles suspended in the nanofiber gel that were then subcutaneously injected into mice. Live animal luminescence imaging using the chemiluminescent reporter molecule luminol showed a significant reduction in inflammation at the site where particles were injected with Dex-PA compared to the site of injection for particles within a control PA in the same animal. Histological evidence suggested a marked reduction in the number of infiltrating inflammatory cells when particles were delivered within Dex-PA nanofiber gels, and very little inflammation was observed at either 3 days or 21 days post-implantation. The use of Dex-PA could facilitate localized anti-inflammatory activity as a component of biomaterials designed for various applications in regenerative medicine and could specifically be a useful module for PA-based therapies. More broadly, these studies define a versatile strategy for facile synthesis of self-assembling peptide-based materials with the ability to control drug release.

Original languageEnglish
Pages (from-to)6823-6832
Number of pages10
JournalBiomaterials
Volume33
Issue number28
DOIs
Publication statusPublished - Oct 2012

Fingerprint

Nanofibers
Amphiphiles
Dexamethasone
Peptides
Gels
Anti-Inflammatory Agents
Cell Transplantation
Biocompatible Materials
Inflammation
Biomaterials
Animals
Pharmaceutical Preparations
Transplantation (surgical)
Tissue Transplantation
Hydrazones
Luminol
Molecules
Regenerative Medicine
Oxidative stress
Polystyrenes

Keywords

  • Cell therapy
  • Controlled drug release
  • Immune response
  • Inflammatory response
  • Peptide amphiphiles
  • Self-assembly

ASJC Scopus subject areas

  • Biomaterials
  • Bioengineering
  • Ceramics and Composites
  • Mechanics of Materials
  • Biophysics

Cite this

Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. / Webber, Matthew J.; Matson, John B.; Tamboli, Vibha K.; Stupp, Samuel I.

In: Biomaterials, Vol. 33, No. 28, 10.2012, p. 6823-6832.

Research output: Contribution to journalArticle

Webber, Matthew J. ; Matson, John B. ; Tamboli, Vibha K. ; Stupp, Samuel I. / Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response. In: Biomaterials. 2012 ; Vol. 33, No. 28. pp. 6823-6832.
@article{a1ed4b33477f454f82aa6a57dd71f85b,
title = "Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response",
abstract = "New biomaterials that have the ability to locally suppress an immune response could have broad therapeutic use in the treatment of diseases characterized by acute or chronic inflammation or as a strategy to facilitate improved efficacy in cell or tissue transplantation. We report here on the preparation of a modular peptide amphiphile (PA) capable of releasing an anti-inflammatory drug, dexamethasone (Dex), by conjugation via a labile hydrazone linkage. This molecule self-assembled in water into long supramolecular nanofibers when mixed with a similar PA lacking the drug conjugate, and the addition of calcium salt to screen electrostatic repulsion between nanofibers promoted gel formation. These nanofiber gels demonstrated sustained release of soluble Dex for over one month in physiologic media. The Dex released from these gels maintained its anti-inflammatory activity when evaluated in vitro using a human inflammatory reporter cell line and furthermore preserved cardiomyocyte viability upon induced oxidative stress. The ability of this gel to mitigate the inflammatory response in cell transplantation strategies was evaluated using cell-surrogate polystyrene microparticles suspended in the nanofiber gel that were then subcutaneously injected into mice. Live animal luminescence imaging using the chemiluminescent reporter molecule luminol showed a significant reduction in inflammation at the site where particles were injected with Dex-PA compared to the site of injection for particles within a control PA in the same animal. Histological evidence suggested a marked reduction in the number of infiltrating inflammatory cells when particles were delivered within Dex-PA nanofiber gels, and very little inflammation was observed at either 3 days or 21 days post-implantation. The use of Dex-PA could facilitate localized anti-inflammatory activity as a component of biomaterials designed for various applications in regenerative medicine and could specifically be a useful module for PA-based therapies. More broadly, these studies define a versatile strategy for facile synthesis of self-assembling peptide-based materials with the ability to control drug release.",
keywords = "Cell therapy, Controlled drug release, Immune response, Inflammatory response, Peptide amphiphiles, Self-assembly",
author = "Webber, {Matthew J.} and Matson, {John B.} and Tamboli, {Vibha K.} and Stupp, {Samuel I}",
year = "2012",
month = "10",
doi = "10.1016/j.biomaterials.2012.06.003",
language = "English",
volume = "33",
pages = "6823--6832",
journal = "Biomaterials",
issn = "0142-9612",
publisher = "Elsevier BV",
number = "28",

}

TY - JOUR

T1 - Controlled release of dexamethasone from peptide nanofiber gels to modulate inflammatory response

AU - Webber, Matthew J.

AU - Matson, John B.

AU - Tamboli, Vibha K.

AU - Stupp, Samuel I

PY - 2012/10

Y1 - 2012/10

N2 - New biomaterials that have the ability to locally suppress an immune response could have broad therapeutic use in the treatment of diseases characterized by acute or chronic inflammation or as a strategy to facilitate improved efficacy in cell or tissue transplantation. We report here on the preparation of a modular peptide amphiphile (PA) capable of releasing an anti-inflammatory drug, dexamethasone (Dex), by conjugation via a labile hydrazone linkage. This molecule self-assembled in water into long supramolecular nanofibers when mixed with a similar PA lacking the drug conjugate, and the addition of calcium salt to screen electrostatic repulsion between nanofibers promoted gel formation. These nanofiber gels demonstrated sustained release of soluble Dex for over one month in physiologic media. The Dex released from these gels maintained its anti-inflammatory activity when evaluated in vitro using a human inflammatory reporter cell line and furthermore preserved cardiomyocyte viability upon induced oxidative stress. The ability of this gel to mitigate the inflammatory response in cell transplantation strategies was evaluated using cell-surrogate polystyrene microparticles suspended in the nanofiber gel that were then subcutaneously injected into mice. Live animal luminescence imaging using the chemiluminescent reporter molecule luminol showed a significant reduction in inflammation at the site where particles were injected with Dex-PA compared to the site of injection for particles within a control PA in the same animal. Histological evidence suggested a marked reduction in the number of infiltrating inflammatory cells when particles were delivered within Dex-PA nanofiber gels, and very little inflammation was observed at either 3 days or 21 days post-implantation. The use of Dex-PA could facilitate localized anti-inflammatory activity as a component of biomaterials designed for various applications in regenerative medicine and could specifically be a useful module for PA-based therapies. More broadly, these studies define a versatile strategy for facile synthesis of self-assembling peptide-based materials with the ability to control drug release.

AB - New biomaterials that have the ability to locally suppress an immune response could have broad therapeutic use in the treatment of diseases characterized by acute or chronic inflammation or as a strategy to facilitate improved efficacy in cell or tissue transplantation. We report here on the preparation of a modular peptide amphiphile (PA) capable of releasing an anti-inflammatory drug, dexamethasone (Dex), by conjugation via a labile hydrazone linkage. This molecule self-assembled in water into long supramolecular nanofibers when mixed with a similar PA lacking the drug conjugate, and the addition of calcium salt to screen electrostatic repulsion between nanofibers promoted gel formation. These nanofiber gels demonstrated sustained release of soluble Dex for over one month in physiologic media. The Dex released from these gels maintained its anti-inflammatory activity when evaluated in vitro using a human inflammatory reporter cell line and furthermore preserved cardiomyocyte viability upon induced oxidative stress. The ability of this gel to mitigate the inflammatory response in cell transplantation strategies was evaluated using cell-surrogate polystyrene microparticles suspended in the nanofiber gel that were then subcutaneously injected into mice. Live animal luminescence imaging using the chemiluminescent reporter molecule luminol showed a significant reduction in inflammation at the site where particles were injected with Dex-PA compared to the site of injection for particles within a control PA in the same animal. Histological evidence suggested a marked reduction in the number of infiltrating inflammatory cells when particles were delivered within Dex-PA nanofiber gels, and very little inflammation was observed at either 3 days or 21 days post-implantation. The use of Dex-PA could facilitate localized anti-inflammatory activity as a component of biomaterials designed for various applications in regenerative medicine and could specifically be a useful module for PA-based therapies. More broadly, these studies define a versatile strategy for facile synthesis of self-assembling peptide-based materials with the ability to control drug release.

KW - Cell therapy

KW - Controlled drug release

KW - Immune response

KW - Inflammatory response

KW - Peptide amphiphiles

KW - Self-assembly

UR - http://www.scopus.com/inward/record.url?scp=84863996309&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84863996309&partnerID=8YFLogxK

U2 - 10.1016/j.biomaterials.2012.06.003

DO - 10.1016/j.biomaterials.2012.06.003

M3 - Article

VL - 33

SP - 6823

EP - 6832

JO - Biomaterials

JF - Biomaterials

SN - 0142-9612

IS - 28

ER -